$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-038/00
  • C07K-005/00
  • C07K-007/00
  • A01N-038/17
출원번호 US-0302596 (1999-04-30)
발명자 / 주소
  • Coolidge Thomas R.
  • Ehlers Mario R. W.
출원인 / 주소
  • BioNebraska, Inc.
대리인 / 주소
    Zarley, McKee, Thomte, Voorhees & Sease
인용정보 피인용 횟수 : 92  인용 특허 : 3

초록

Individuals in need of treatment of ischemia-related reperfusion are treated, preferably intravenously, with a composition which includes a compound which binds to a receptor for the glucagon-like peptide-1. The invention relates to both the method and compositions for such treatment.

대표청구항

[ What is claimed is:] [1.]1. A method for amelioration of organ tissue injury caused by reperfusion of blood flow following a period of ischemia, which comprises:administering to an individual in need of such treatment an effective amount of a composition which includes a compound which binds to a

이 특허에 인용된 특허 (3)

  1. Tiholiz Ivan C. (18250 Roscoe Blvd. Northridge CA 91324), Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states.
  2. Mishra Lopa, Nucleic acids encoding proteins for early liver development.
  3. Hoover Dennis J. ; Hulin Bernard ; Martin William H. ; Phillips Douglas ; Treadway Judith L., Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors.

이 특허를 인용한 특허 (92)

  1. Rosen, Craig A.; Haseltine, William A.; Ballance, David J.; Turner, Andrew J.; Ruben, Steven M., Albumin fusion proteins.
  2. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  3. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  4. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  5. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  6. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  7. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  8. Rosen, Craig A.; Haseltine, William A.; Ruben, Steven M., Albumin fusion proteins.
  9. Rosen,Craig A.; Haseltine,William A.; Ruben,Steven M., Albumin fusion proteins.
  10. Rosen,Craig A.; Haseltine,William A.; Ballance,David J.; Turner,Andrew J.; Ruben,Steven M., Albumin fusion proteins comprising GLP-1 polypeptides.
  11. Werner, Ulrich; Rotthauser, Barbel, Combination of an insulin and a GLP-1 agonist.
  12. Werner, Ulrich; Rotthauser, Barbel, Combination of an insulin and a GLP-1-agonist.
  13. Hathaway, David R.; Coolidge, Thomas R., Compositions and methods for treating peripheral vascular disease.
  14. Leung, Karling Alice, Compositions, devices and methods of use thereof for the treatment of cancers.
  15. Alessi, Thomas R.; Leung, Karling Alice; Mercer, Ryan D.; Negulescu, Cristina G.; Rohloff, Catherine M.; Yang, Bing, Devices, formulations, and methods for delivery of multiple beneficial agents.
  16. Prickett, Kathryn S.; Young, Andrew A., Exendins and exendin agonists modified with albumin.
  17. Prickett, Kathryn S.; Young, Andrew A., Exendins and exendin agonists modified with polyamino acids.
  18. DiPerna, Paul M, Flow regulating stopcocks and related methods.
  19. Fleer,Reinhard; Fournier,Alain; Guitton,Jean Dominique; Jung,G��rard; Yeh,Patrice, Fusion polypeptides of human serum albumin and a therapeutically active polypeptide.
  20. Shelton, Anne Pernille Tofteng; Nørregaard, Pia; Deryabina, Maria Alexandrovna; Larsen, Bjarne Due; Fog, Jacob Ulrik, GIP agonist compounds and methods.
  21. Shelton, Anne Pernille Tofteng; Nørregaard, Pia; Fog, Jacob Ulrik; Knudsen, Carsten Boye, GIP-GLP-1 dual agonist compounds and methods.
  22. Tolborg, Jakob Lind; Neerup, Trine Skovlund Ryge; Fosgerau, Keld; Østerlund, Torben; Almholt, Dorthe Lennert Christensen; Larsen, Lone Frost, GLP-1 receptor agonist peptide gastrin conjugates.
  23. Tolborg, Jakob Lind; Fosgerau, Keld; Nørregaard, Pia; Just, Rasmus; Riber, Ditte; Hamprecht, Dieter Wolfgang; Augustin, Robert; Thomas, Leo; Rist, Wolfgang, Glucagon analogues.
  24. Tolborg, Jakob Lind; Fosgerau, Keld; Nørregaard, Pia; Just, Rasmus; Riber, Ditte; Hamprecht, Dieter Wolfgang; Augustin, Robert; Thomas, Leo; Rist, Wolfgang, Glucagon analogues.
  25. Just, Rasmus; Riber, Ditte; Shelton, Anne Pernille Tofteng; Østerlund, Torben; Hansen, Kate; Jessen, Lene, Glucagon-GLP-1-GIP triple agonist compounds.
  26. Fleer,Reinhard; Fournier,Alain; Guitton,Jean Dominique; Jung,G챕rard; Yeh,Patrice, Hormone and albumin fusion protein.
  27. Sheppard, Paul O.; Bishop, Paul D., Human Zven polypeptides.
  28. Sheppard, Paul O.; Bishop, Paul D., Human zven polynucleotides.
  29. Gonnelli, Robert R.; McAllister, Devin V.; Levesque, Steven F., Hydraulically actuated pump for fluid administration.
  30. Gonnelli, Robert R.; McAllister, Devin V.; Levesque, Steven F., Hydraulically actuated pump for fluid administration.
  31. Gonnelli, Robert R.; McAllister, Devin V.; Levesque, Steven F., Hydraulically actuated pump for long duration medicament administration.
  32. Smith, Jay S.; Cole, Michael R.; Whitson, Amy K., Implant placement guide.
  33. Smith, Jay S.; Cole, Michael R.; Whitson, Amy K., Implant placement guide.
  34. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  35. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  36. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  37. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  38. Verhoef, Erik T.; DiPerna, Paul M.; Rosinko, Mike; Williamson, Mark; Kruse, Geoffrey A.; Ulrich, Thomas R.; Lamb, Phil; Saint, Sean; Michaud, Michael; Trevaskis, William, Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  39. Souhami, Elisabeth; Silvestre, Louise, Insulin glargine/lixisenatide fixed ratio formulation.
  40. Habener, Joel F., Insulinotropic hormone and uses thereof.
  41. Habener,Joel F.; Mojsov,Svetlana, Insulinotropic hormone derivatives and uses thereof.
  42. Holderman, Susan D.; Chan, Chung, Isolated nucleic acid sequence comprising SEQ ID NO: 14 and methods of using said nucleic acid sequence.
  43. Bridon, Dominique P.; Rasamoelisolo, Michele; Thibaudeau, Karen; Huang, Xicai; Beliveau, Richard, Long lasting anti-angiogenic peptides.
  44. Coolidge, Thomas R.; Ehlers, Mario R. W., Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain.
  45. Bousquet Gagnon,Nathalie; Quraishi,Omar; Bridon,Dominique P., Method for purification of albumin conjugates.
  46. Bridon, Dominique P.; Castaigne, Jean-Paul; Thibaudeau, Karen, Method of treatment of diabetes and/or obesity with reduced nausea side effect.
  47. Sheppard, Paul O.; Bishop, Paul D., Method of using Zven antibodies.
  48. Gonnelli, Robert R., Methods and devices for delivering GLP-1 and uses thereof.
  49. Drucker, Daniel J.; Baggio, Laurie Lynn, Methods for treating disorders of the gastrointestinal tract using a GLP-1 agonist.
  50. Jucker, Beat M.; Lepore, John J.; Olson, Eric J., Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection.
  51. Bridon, Dominique P.; L'Archeveque, Benoit; Holmes, Darren L.; Leblanc, Anouk; St. Pierre, Serge, Methods involving long lasting synthetic exendin-4 peptide conjugates.
  52. Eliaz, Rom Ezer; Zhang, Yuanpeng; Rohloff, Catherine Manya; Weeks, Eric William; Junnarkar, Gunjan, Methods of manufacturing viscous liquid pharmaceutical formulations.
  53. Thompson, Penny J.; Lewis, Katherine E.; Garcia, Richard M.; West, Robert R.; Sheppard, Paul O., Methods of modulating gastrointestinal contractility.
  54. Prickett, Kathryn S.; Young, Andrew A., Methods of treating diabetes with albumin-conjugated exendin peptides.
  55. Prickett, Karthryn S.; Young, Andrew A., Modified exendins and exendin agonists.
  56. Prickett, Kathryn S.; Young, Andrew A., Modified exendins and exendin agonists.
  57. Prickett, Kathryn S.; Young, Andrew A., Modified exendins and exendin agonists.
  58. Gonnelli, Robert R.; Levesque, Steven F.; Nardi, Ronald V., Multi-cartridge fluid delivery device.
  59. Gonnelli, Robert R.; Levesque, Steven F.; Nardi, Ronald V., Multi-cartridge fluid delivery device.
  60. Levesque, Steven F.; Gonnelli, Robert R.; Nardi, Ronald V., Multi-cartridge fluid delivery device.
  61. Sarubbi, Donald J., Oral GLP-1 formulations.
  62. Alessi, Thomas R.; Mercer, Ryan D.; Rohloff, Catherine M.; Yang, Bing, Osmotic delivery device comprising an insulinotropic peptide and uses thereof.
  63. Neerup, Trine Skovlund Ryge; Østerlund, Torben; Tolborg, Jakob Lind; Fosgerau, Keld; Martensson, Ulrika; Brorson, Marianne; Rolsted, Kamilla, Peptide conjugates of GLP-1 receptor agonists and gastrin and their use.
  64. Neerup, Trine Skovlund Ryge; Østerlund, Torben; Tolborg, Jakob Lind; Fosgerau, Keld; Mårtensson, Ulrika; Brorson, Marianne; Rolsted, Kamilla, Peptide conjugates of GLP-1 receptor agonists and gastrin and their use.
  65. Niemoeller, Elisabeth; Silvestre, Louise; Boka, Gabor; Miossec, Patrick, Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin.
  66. Niemöeller, Elisabeth; Müehlen-Bartmer, Isabel; Silvestre, Louise; Boka, Gabor; Miossec, Patrick, Pharmaceutical combination for use in glycemic control in diabetes type 2 patients.
  67. Brunner-Schwarz, Anette; Mueller, Werner; Siefke-Henzler, Verena, Pharmaceutical composition comprising a GLP-1 agonist and methionine.
  68. Hagendorf, Annika; Hauck, Gerrit; Mueller, Werner; Schoettle, Isabell; Siefke-Henzler, Verena; Tertsch, Katrin, Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine.
  69. Brunner-Schwarz, Anette; Mueller, Werner; Siefke-Henzler, Verena, Pharmaceutical composition comprising a GLP-1-agonist and methionine.
  70. Hess, Sibylle; Hoelscher, Christian; Boehme, Andrees; Menut, Agnes; Pradier, Laurent; Taupin, Veronique, Pharmaceutical composition for use in the treatment of a neurodegenerative disease.
  71. Hess, Sibylle; Hölscher, Christian, Pharmaceutical composition for use in the treatment of a neurodegenerative disease.
  72. Bush, Mark A.; Stewart, Murray W.; Yang, Yonghong, Pharmaceutical compositions.
  73. Alessi, Thomas R.; Luskey, Kenneth, Rapid establishment and/or termination of substantial steady-state drug delivery.
  74. DiPerna, Paul M., Slideable flow metering devices and related methods.
  75. Brown, David, Solute concentration measurement device and related methods.
  76. Rohloff, Catherine M.; Chen, Guohua; Luk, Andrew S.; Ayer, Rupal A.; Houston, Paul R.; Desjardin, Michael A.; Zamora, Pauline; Lam, Stan, Solvent/polymer solutions as suspension vehicles.
  77. Ebbehøj, Kirsten; Jepsen, Trine; Knudsen, Carsten Boye; Larsen, Bjarne Due; Knott, David, Stabilized Exendin-4 compounds.
  78. Bley, Oliver; Loos, Petra; Bidlingmaier, Bernd; Kamm, Walter; Berchtold, Harald, Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives.
  79. Bley, Oliver; Loos, Petra; Bidlingmaier, Bernd; Kamm, Walter; Berchtold, Harald, Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives.
  80. Bley, Oliver; Loos, Petra; Bidlingmaier, Bernd; Kamm, Walter; Berchtold, Harald, Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives.
  81. Bley, Oliver; Loos, Petra; Bidlingmaier, Bernd; Kamm, Walter; Berchtold, Harald, Stabilized pharmaceutical formulations of insulin aspart.
  82. Rosinko, Michael J.; Kruse, Geoffrey A.; Harris, Paul, System and method for detecting occlusions in an infusion pump.
  83. Metzmaker, Thomas; Saint, Sean; Michaud, Michael; Rosinko, Michael J.; Swanson, Vance, Systems including vial adapter for fluid transfer.
  84. Alessi, Thomas R.; Baron, Michelle, Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c.
  85. Hathaway, David R.; Baron, Alain D., Treatment of cardiac arrhythmias.
  86. Hathaway, David R.; Baron, Alain D., Treatment of cardiac arrhythmias with GLP-1 receptor ligands.
  87. Coolidge, Thomas R.; Ehlers, Mario, Treatment of hibernating myocardium with an exendin peptide.
  88. Belder, Rene; Johnston, Peter; Lawson, Francesca; Ping, Lin; Wei, Xiaodan, Treatment of type 2 diabetes mellitus patients.
  89. DiPerna, Paul M., Two chamber pumps and related methods.
  90. Lautenbach, Scott C.; De La Serna, Pedro E.; Zamora, Pauline C.; Desjardin, Michael A., Two-piece, internal-channel osmotic delivery system flow modulator.
  91. Boka, Gabor; Miossec, Patrick; Silvestre, Louise, Use of AVE0010 for the treatment of diabetes mellitus type 2.
  92. Anderson, Christen; Liu, Que, Use of exendin and analogs thereof to delay or prevent cardiac remodeling.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로